why choose us

First received: October 05, 2023

Clinical Trial: A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Infection.

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Respiratory Syncytial Viruses

Study Type: OBSERVATIONAL


Official Title: Retrospective Study Evaluating ABRYSVO Vaccine Effectiveness Against Severe Lower Respiratory Tract Infection in Older Adults

Brief Summary: The main purpose of this study is to learn about the effectiveness of Pfizer's ABRYSVO vaccine.This vaccine helps to prevent infections caused by Respiratory Syncytial Virus (RSV).RSV is a virus that can cause infections in the airways.These symptoms can be cold-like symptoms, but in some cases can lead to severe symptoms or hospitalization.This study uses only healthcare data that are already collected from routine visits to healthcare providers.This means that participants will not be actively enrolled in…

Read more